Founded in 2021 by Robin Roumengas and Dr. David Luu, Juisci provides a mobile-first platform that uses proprietary AI trained on scientific literature to produce summaries, article recommendations, videos, podcasts and infographics. The service helps healthcare professionals combat information overload by delivering clear, reliable insights drawn from the rapidly expanding body of medical research. Juisci reports more than 200,000 users across 60 countries and 10 languages, claiming it can save clinicians up to eight hours per week. The company’s client roster exceeds 30 organisations, including Sanofi, UCB, Takeda, bioMérieux, Johnson & Johnson, Air Liquide, L’Oréal, and multiple hospitals and scientific societies. Revenue figures were not disclosed, but the firm positions itself as a partner to pharmaceutical, MedTech and healthcare institutions. With fresh capital, Juisci plans to boost R&D, scale its team and accelerate international expansion, prioritising growth in the U.S. market.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025